555 related articles for article (PubMed ID: 26295972)
1. Colorectal cancer models for novel drug discovery.
Golovko D; Kedrin D; Yilmaz ÖH; Roper J
Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
[TBL] [Abstract][Full Text] [Related]
2. Advances in the use of 3D colorectal cancer models for novel drug discovery.
Baião A; Dias S; Soares AF; Pereira CL; Oliveira C; Sarmento B
Expert Opin Drug Discov; 2022 Jun; 17(6):569-580. PubMed ID: 35343351
[TBL] [Abstract][Full Text] [Related]
3. Priceless GEMMs: genetically engineered mouse models for colorectal cancer drug development.
Roper J; Hung KE
Trends Pharmacol Sci; 2012 Aug; 33(8):449-55. PubMed ID: 22739258
[TBL] [Abstract][Full Text] [Related]
4. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
5. Overview of genetically engineered mouse models of colorectal carcinoma to enable translational biology and drug development.
Roper J; Martin ES; Hung KE
Curr Protoc Pharmacol; 2014 Jun; 65():14.29.1-10. PubMed ID: 24934606
[TBL] [Abstract][Full Text] [Related]
6. Animal models for modeling pancreatic cancer and novel drug discovery.
Bisht S; Feldmann G
Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
[TBL] [Abstract][Full Text] [Related]
7. Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery.
Ruggeri BA; Camp F; Miknyoczki S
Biochem Pharmacol; 2014 Jan; 87(1):150-61. PubMed ID: 23817077
[TBL] [Abstract][Full Text] [Related]
8. The use of natural products in colorectal cancer drug discovery.
Miura K; Satoh M; Kinouchi M; Yamamoto K; Hasegawa Y; Kakugawa Y; Kawai M; Uchimi K; Aizawa H; Ohnuma S; Kajiwara T; Sakurai H; Fujiya T
Expert Opin Drug Discov; 2015 Apr; 10(4):411-26. PubMed ID: 25724579
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity Detection of Micrometastases Generated by GFP Lentivirus-transduced Organoids Cultured from a Patient-derived Colon Tumor.
Okazawa Y; Mizukoshi K; Koyama Y; Okubo S; Komiyama H; Kojima Y; Goto M; Habu S; Hino O; Sakamoto K; Orimo A
J Vis Exp; 2018 Jun; (136):. PubMed ID: 29985333
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Feng L; Yao HP; Wang W; Zhou YQ; Zhou J; Zhang R; Wang MH
Clin Cancer Res; 2014 Dec; 20(23):6045-58. PubMed ID: 25294907
[TBL] [Abstract][Full Text] [Related]
11. Advanced Colorectal Cancer Orthotopic Patient-Derived Xenograft Models for Cancer and Stem Cell Research.
Chicote I; Cámara JA; Palmer HG
Methods Mol Biol; 2020; 2171():321-329. PubMed ID: 32705653
[TBL] [Abstract][Full Text] [Related]
12. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids.
de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ
Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft models of colorectal cancer in pre-clinical research: a systematic review.
Brown KM; Xue A; Mittal A; Samra JS; Smith R; Hugh TJ
Oncotarget; 2016 Oct; 7(40):66212-66225. PubMed ID: 27517155
[TBL] [Abstract][Full Text] [Related]
14. Mouse models in squamous cell lung cancer: impact for drug discovery.
Singh AP; Adrianzen Herrera D; Zhang Y; Perez-Soler R; Cheng H
Expert Opin Drug Discov; 2018 Apr; 13(4):347-358. PubMed ID: 29394493
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery in prostate cancer mouse models.
Valkenburg KC; Pienta KJ
Expert Opin Drug Discov; 2015; 10(9):1011-24. PubMed ID: 26027638
[TBL] [Abstract][Full Text] [Related]
16. Mouse models of colorectal cancer: Past, present and future perspectives.
Bürtin F; Mullins CS; Linnebacher M
World J Gastroenterol; 2020 Apr; 26(13):1394-1426. PubMed ID: 32308343
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of a potent MEK inhibitor, TAK-733, against colorectal cancer cell lines and patient derived xenografts.
Lieu CH; Klauck PJ; Henthorn PK; Tentler JJ; Tan AC; Spreafico A; Selby HM; Britt BC; Bagby SM; Arcaroli JJ; Messersmith WA; Pitts TM; Eckhardt SG
Oncotarget; 2015 Oct; 6(33):34561-72. PubMed ID: 26439693
[TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
[TBL] [Abstract][Full Text] [Related]
20. The latest animal models of ovarian cancer for novel drug discovery.
Magnotti E; Marasco WA
Expert Opin Drug Discov; 2018 Mar; 13(3):249-257. PubMed ID: 29338446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
